![Rakhi Kumar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rakhi Kumar
Directeur/Membre du Conseil chez
NEUROPACE, INC.
Fortune : 604 771 $ au 31/08/2026
Profil
Rakhi Kumar is currently an Independent Director at NeuroPace, Inc. since 2021, Treasurer & Director at Roivant Social Ventures, Inc. since 2015, Independent Director at Amanat Acquisition Corp.
starting 2026, and a Member of the Financial Accounting Standards Board.
Former roles include Senior Managing Director & Head of ESG Investments at SSgA Funds Management, Inc. from 2011 to 2020, Chief Accounting Officer at Roivant Sciences Ltd. from 2018 to 2025, Chief Accounting Officer at Roivant Sciences, Inc. from 2015 to 2025, Chief Accounting Officer at Montes Archimedes Acquisition Corp., Consultant at Mahajan & Aibara Consulting Pvt Ltd., Policy Advisor at The Institute of International Finance, Inc., and Associate Analyst at Moody's Investors Service, Inc. Education includes an MBA from Yale University in 2002, graduate studies at the University of Hartford, and an undergraduate degree from the University of Mumbai in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEUROPACE, INC. 0,07 % | 19/06/2026 | 23 039 ( 0,07 % ) | 337 521 $ | 31/08/2026 |
1,15 % | 20/05/2026 | 25 000 ( 1,15 % ) | 267 250 $ | 31/08/2026 |
Postes actifs de Rakhi Kumar
| Sociétés | Poste | Début |
|---|---|---|
| NEUROPACE, INC. | Directeur/Membre du Conseil | 01/04/2021 |
Roivant Social Ventures, Inc.
 Roivant Social Ventures, Inc. Roivant Social Ventures, Inc. is a not-for-profit social impact organization dedicated to advancing health equity by applying private sector strategies to biopharma innovation and healthcare delivery. The private company is based in New York, NY. The company focuses on ensuring equitable access to medicines and medical care regardless of geography, wealth, or insurance status by investing in early-stage companies developing therapies for underserved patient populations, incubating healthcare-focused social entrepreneurs, and embedding drug development education in academic institutions through fellowships and internships to promote diversity in the biopharma industry and clinical trials. Roivant Social Ventures also partners with companies, institutes, and organizations to create systemic improvements in healthcare access and delivery, with key focus areas including gene therapy access, increasing diversity in clinical trials, and fostering diversity, equity, and inclusion opportunities for future biopharma leaders. Lindsay Androski has been the CEO of the company since 2016. | Directeur/Membre du Conseil | 01/09/2015 |
Financial Accounting Standards Board
 Financial Accounting Standards Board Miscellaneous Commercial ServicesCommercial Services Provides oversight of US accounting standards | Corporate Officer/Principal | - |
Anciens postes connus de Rakhi Kumar
| Sociétés | Poste | Fin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Comptroller/Controller/Auditor | 20/02/2025 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Comptroller/Controller/Auditor | 20/02/2025 |
SSgA Funds Management, Inc.
 SSgA Funds Management, Inc. Investment ManagersFinance SSgA FM utilizes several methods of investment analysis across a wide array of investment strategies when formulating investment advice or managing assets. The firm does not rely on one type of investment analysis over another and does not recommend one particular type of security. They seek to utilize the most prudent methods of investment analysis based upon certain characteristics of the investment strategy and the current market conditions, as applicable. | Gestionnaire de Portefeuille-Actions | 01/05/2020 |
| ROIVANT SCIENCES LTD. | Comptroller/Controller/Auditor | - |
The Institute of International Finance, Inc.
 The Institute of International Finance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a financial institute | Corporate Officer/Principal | - |
Formation de Rakhi Kumar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
SSgA Funds Management, Inc.
SSgA Funds Management, Inc. Investment ManagersFinance SSgA FM utilizes several methods of investment analysis across a wide array of investment strategies when formulating investment advice or managing assets. The firm does not rely on one type of investment analysis over another and does not recommend one particular type of security. They seek to utilize the most prudent methods of investment analysis based upon certain characteristics of the investment strategy and the current market conditions, as applicable. | Finance |
Moody's Investors Service, Inc.
 Moody's Investors Service, Inc. Investment ManagersFinance Provides investment research | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
 University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroPace, Inc.
 NeuroPace, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders | Health Technology |
The Institute of International Finance, Inc.
The Institute of International Finance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a financial institute | Commercial Services |
Financial Accounting Standards Board
Financial Accounting Standards Board Miscellaneous Commercial ServicesCommercial Services Provides oversight of US accounting standards | Commercial Services |
Mahajan & Aibara Consulting Pvt Ltd. | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Roivant Social Ventures, Inc.
Roivant Social Ventures, Inc. Roivant Social Ventures, Inc. is a not-for-profit social impact organization dedicated to advancing health equity by applying private sector strategies to biopharma innovation and healthcare delivery. The private company is based in New York, NY. The company focuses on ensuring equitable access to medicines and medical care regardless of geography, wealth, or insurance status by investing in early-stage companies developing therapies for underserved patient populations, incubating healthcare-focused social entrepreneurs, and embedding drug development education in academic institutions through fellowships and internships to promote diversity in the biopharma industry and clinical trials. Roivant Social Ventures also partners with companies, institutes, and organizations to create systemic improvements in healthcare access and delivery, with key focus areas including gene therapy access, increasing diversity in clinical trials, and fostering diversity, equity, and inclusion opportunities for future biopharma leaders. Lindsay Androski has been the CEO of the company since 2016. |
